The overlooked elephant in the room
Almost lost amid the chaos and carnage depicted when an angry mob descended on the U.S. Capitol last week was a development that may affect long-term care more directly.
Almost lost amid the chaos and carnage depicted when an angry mob descended on the U.S. Capitol last week was a development that may affect long-term care more directly.
Let me spare you a lot of unnecessary reading and worry, while offering some advice about the road ahead.
It’s entirely possible there may be some real curve balls tucked into next year’s calendar. But it’s also likely that many semi-sleepless nights will be caused by recurring nightmares.
Moderna’s COVID-19 vaccine is 94% effective in preventing symptomatic illness, according to information released Tuesday. The initial review’s findings appear to set the table for federal authorization and nationwide distribution.
Long-term care residents will be among the first people in the nation to receive COVID-19 vaccinations. On Tuesday, Food and Drug Administration staff recommended that they be checked for possible cases of Bell’s palsy.
“I believe this is the weapon that will end the war.” New York Gov. Andrew M. Cuomo made the statement at the first known clinically authorized vaccination Monday morning at the Long Island Jewish Medical Center. But for many on long-term care’s front lines, doubts remain about a vaccine less than one year in the making.
The Human Animal Bond Research Institute announced a new research project to see whether horses might be able to help reduce symptoms among people with Parkinson’s disease.
Two headlines we ran Friday probably tell you most of what you need to know about the current state of long-term care.
I was recently talking to a sibling who moved out West. Thanks to the miracle of remote work, he was able to ditch cold winters while keeping his day job. As they say, nice work if you can get it.
When I hear about innovation in long-term care, I sometimes have to stifle a chuckle.